Kuroda K - Search Results

1

Correlation between HLA alleles and EGFR mutation in Japanese patients with adenocarcinoma of the lung.

Uramoto H, So T, Nagata Y, Kuroda K, Shigematsu Y, Baba T, So T, Takenoyama M, Hanagiri T, Yasumoto K. Uramoto H, et al. Among authors: kuroda k. J Thorac Oncol. 2010 Aug;5(8):1136-42. doi: 10.1097/JTO.0b013e3181e0b993. J Thorac Oncol. 2010. PMID: 20548248 Free article.

2

Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.

Baba T, Hanagiri T, Ichiki Y, Kuroda K, Shigematsu Y, Mizukami M, Sugaya M, Takenoyama M, Sugio K, Yasumoto K. Baba T, et al. Among authors: kuroda k. Cancer Sci. 2007 Nov;98(11):1795-802. doi: 10.1111/j.1349-7006.2007.00586.x. Epub 2007 Aug 28. Cancer Sci. 2007. PMID: 17725806 Free PMC article.

3

Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency mice.

Mizukami M, Hanagiri T, Yasuda M, Kuroda K, Shigematsu Y, Baba T, Fukuyama T, Nagata Y, So T, Ichiki Y, Sugaya M, So T, Takenoyama M, Sugio K, Yasumoto K. Mizukami M, et al. Among authors: kuroda k. Cancer Res. 2007 Sep 1;67(17):8351-7. doi: 10.1158/0008-5472.CAN-06-3889. Cancer Res. 2007. PMID: 17804751

4

Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan.

Nagata Y, Hanagiri T, Mizukami M, Kuroda K, Shigematsu Y, Baba T, Ichiki Y, Yasuda M, So T, Takenoyama M, Sugio K, Nagashima A, Yasumoto K. Nagata Y, et al. Among authors: kuroda k. Lung Cancer. 2009 Jul;65(1):91-7. doi: 10.1016/j.lungcan.2008.10.012. Epub 2008 Dec 2. Lung Cancer. 2009. PMID: 19054590

5

Malignant mesothelioma-associated antigens recognized by tumor-infiltrating B cells and the clinical significance of the antibody titers.

Shigematsu Y, Hanagiri T, Kuroda K, Baba T, Mizukami M, Ichiki Y, Yasuda M, Takenoyama M, Sugio K, Yasumoto K. Shigematsu Y, et al. Among authors: kuroda k. Cancer Sci. 2009 Jul;100(7):1326-34. doi: 10.1111/j.1349-7006.2009.01181.x. Epub 2009 Apr 30. Cancer Sci. 2009. PMID: 19432887 Free PMC article.

6

Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.

Shigematsu Y, Hanagiri T, Shiota H, Kuroda K, Baba T, Mizukami M, So T, Ichiki Y, Yasuda M, So T, Takenoyama M, Yasumoto K. Shigematsu Y, et al. Among authors: kuroda k. Lung Cancer. 2010 Apr;68(1):105-10. doi: 10.1016/j.lungcan.2009.05.010. Epub 2009 Jul 9. Lung Cancer. 2010. PMID: 19545928

7

Identification of ribosomal protein L19 as a novel tumor antigen recognized by autologous cytotoxic T lymphocytes in lung adenocarcinoma.

Kuroda K, Takenoyama M, Baba T, Shigematsu Y, Shiota H, Ichiki Y, Yasuda M, Uramoto H, Hanagiri T, Yasumoto K. Kuroda K, et al. Cancer Sci. 2010 Jan;101(1):46-53. doi: 10.1111/j.1349-7006.2009.01351.x. Epub 2009 Sep 9. Cancer Sci. 2010. PMID: 19799608 Free PMC article.

8

Identification of a lung cancer antigen evading CTL attack due to loss of human leukocyte antigen (HLA) class I expression.

Baba T, Hanagiri T, Takenoyama M, Shiota H, Kuroda K, Shigematsu Y, Ichiki Y, Uramoto H, So T, Yasumoto K. Baba T, et al. Among authors: kuroda k. Cancer Sci. 2010 Oct;101(10):2115-20. doi: 10.1111/j.1349-7006.2010.01659.x. Epub 2010 Jul 22. Cancer Sci. 2010. PMID: 20649604 Free PMC article.

9

Antitumor activity of human γδ T cells transducted with CD8 and with T-cell receptors of tumor-specific cytotoxic T lymphocytes.

Hanagiri T, Shigematsu Y, Kuroda K, Baba T, Shiota H, Ichiki Y, Nagata Y, Yasuda M, So T, Takenoyama M, Tanaka F. Hanagiri T, et al. Among authors: kuroda k. Cancer Sci. 2012 Aug;103(8):1414-9. doi: 10.1111/j.1349-7006.2012.02337.x. Epub 2012 Jul 6. Cancer Sci. 2012. Retraction in: Cancer Sci. 2014 Jan;105(1):141. doi: 10.1111/cas.12346 PMID: 22621620 Free PMC article. Retracted.

10

Cancer/testis antigen expression as a predictor for epidermal growth factor receptor mutation and prognosis in lung adenocarcinoma.

Baba T, Shiota H, Kuroda K, Shigematsu Y, Ichiki Y, Uramoto H, Hanagiri T, Tanaka F. Baba T, et al. Among authors: kuroda k. Eur J Cardiothorac Surg. 2013 Apr;43(4):759-64. doi: 10.1093/ejcts/ezs426. Epub 2012 Jul 22. Eur J Cardiothorac Surg. 2013. PMID: 22826471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,195 results

Search Page

Filters